{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T10:55:43Z","timestamp":1792839343052,"version":"4.5.0"},"reference-count":98,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.jhep.2019.07.002","type":"journal-article","created":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T19:55:30Z","timestamp":1562874930000},"page":"811-822","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":399,"title":["News in pathophysiology, definition and classification of hepatorenal syndrome: A step beyond the International Club of Ascites (ICA) consensus document"],"prefix":"10.1016","volume":"71","author":[{"given":"Paolo","family":"Angeli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guadalupe","family":"Garcia-Tsao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitra K.","family":"Nadim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chirag R.","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2019.07.002_b0005","series-title":"Diseases of the kidney and urinary tract","first-page":"2179","article-title":"Liver disease and the kidney","author":"Gin\u00e8s","year":"2007"},{"key":"10.1016\/j.jhep.2019.07.002_b0010","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.cgh.2014.07.011","article-title":"Acute Liver Failure Study Group. risk factors and outcomes of acute kidney injury in patients with acute liver failure","volume":"13","author":"Tujios","year":"2015","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10.1016\/j.jhep.2019.07.002_b0015","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","article-title":"Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis","volume":"144","author":"Moreau","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2019.07.002_b0020","first-page":"164","article-title":"Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis","volume":"23","author":"Arroyo","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.07.002_b0025","first-page":"1310","article-title":"Diagnosis, prevention and treatment of the hepatorenal syndrome in cirrhosis a consensus workshop of the International Ascites Club","volume":"56","author":"Salerno","year":"2007","journal-title":"Gut"},{"issue":"Suppl","key":"10.1016\/j.jhep.2019.07.002_b0030","first-page":"1","article-title":"KDIGO clinical practice guideline for acute kidney injury","volume":"2","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.jhep.2019.07.002_b0035","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.jhep.2014.12.029","article-title":"Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the ICA","volume":"62","author":"Angeli","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.07.002_b0040","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1053\/jhep.2003.50084","article-title":"Acute renal failure in patients with cirrhosis: perspectives in the age of MELD","volume":"37","author":"Moreau","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.07.002_b0045","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM199908053410603","article-title":"Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis","volume":"341","author":"Sort","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2019.07.002_b0050","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/hep.1840200619","article-title":"Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis","volume":"20","author":"Follo","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.07.002_b0055","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/hep.21443","article-title":"Renal failure and bacterial infections in patients with cirrhosis: epidemiology and clinical features","volume":"45","author":"Fasolato","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.07.002_b0060","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1053\/j.gastro.2005.09.024","article-title":"Renal failure in patients with cirrhosis and sepsis unrelated to spontaneous bacterial peritonitis: value of MELD score","volume":"129","author":"Terra","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2019.07.002_b0065","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S0016-5085(96)70068-9","article-title":"Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis","volume":"111","author":"Gin\u00e8s","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2019.07.002_b0070","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1136\/gut.2008.176495","article-title":"Combined versus sequential diuretic treatment of ascites in non-azotaemic patients with cirrhosis: results of an open randomised clinical trial","volume":"59","author":"Angeli","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2019.07.002_b0075","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1053\/gast.2000.20189","article-title":"Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial","volume":"119","author":"Akriviadis","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2019.07.002_b0080","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1136\/gut.2008.154120","article-title":"The systemic inflammatory response syndrome is predictive of renal dysfunction in patients with non-paracetamol-induced acute liver failure","volume":"58","author":"Leithead","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2019.07.002_b0085","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.1840080532","article-title":"Peripheral arteriolar vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis","volume":"8","author":"Schrier","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.07.002_b0090","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/hep.20766","article-title":"Circulatory function and hepato-renal syndrome","volume":"42","author":"Ruiz del Arbol","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.07.002_b0095","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1136\/gut.2009.180570","article-title":"Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites","volume":"59","author":"Krag","year":"2010","journal-title":"Gut"},{"issue":"Suppl 1","key":"10.1016\/j.jhep.2019.07.002_b0100","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1016\/j.jhep.2008.01.010","article-title":"Pathogenesis and management of hepatorenal syndrome in patients with cirrhosis","volume":"48","author":"Angeli","year":"2008","journal-title":"J Hepatol."},{"key":"10.1016\/j.jhep.2019.07.002_b0105","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1111\/apt.14052","article-title":"Reversal of hepatorenal syndrome type 1 with terlipressin plus albumin vs. placebo plus albumin in a pooled analysis of the OT-0401 and REVERSE randomised clinical studies","volume":"45","author":"Sanyal","year":"2017","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.jhep.2019.07.002_b0110","article-title":"Terlipressin versus placebo or no intervention for people with cirrhosis and hepatorenal syndrome","volume":"6","author":"Allegretti","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jhep.2019.07.002_b0115","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jhep.2013.03.039","article-title":"Evaluation of the Acute Kidney Injury Network criteria in hospitalized patients with cirrhosis and ascites","volume":"59","author":"Piano","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.07.002_b0120","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1053\/j.gastro.2013.08.051","article-title":"New consensus definition of acute kidney injury accurately predicts 30-day mortality in patients with cirrhosis and infection","volume":"145","author":"Wong","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2019.07.002_b0125","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jhep.2013.04.036","article-title":"A modified acute kidney injury classification for diagnosis and risk stratification of impairment of kidney function in cirrhosis","volume":"59","author":"Fagundes","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.07.002_b0130","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/hep.25735","article-title":"Association of AKI with mortality and complications in hospitalized patients with cirrhosis","volume":"57","author":"Belcher","year":"2013","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jhep.2019.07.002_b0135","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/hep.27077","article-title":"Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures","volume":"60","author":"Bajaj","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.07.002_b0140","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.jhep.2015.07.004","article-title":"Mechanisms of decompensation and organ failure in cirrhosis: from peripheral arterial vasodilation to systemic inflammation hypothesis","volume":"63","author":"Bernardi","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.07.002_b0145","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1002\/hep.28740","article-title":"Systemic inflammation in decompensated cirrhosis: characterization and role in acute-on-chronic liver failure","volume":"64","author":"Cl\u00e0ria","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.07.002_b0150","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3389\/fimmu.2019.00476","article-title":"Addressing profiles of systemic inflammation across the different clinical phenotypes of acutely decompensated cirrhosis","volume":"10","author":"Trebicka","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhep.2019.07.002_b0155","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.cld.2015.10.001","article-title":"Epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in the United States and the rest of the world","volume":"20","author":"Sayiner","year":"2016","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhep.2019.07.002_b0160","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cld.2015.10.010","article-title":"Progression and natural history of nonalcoholic fatty liver disease in adults","volume":"20","author":"Marengo","year":"2016","journal-title":"Clin Liver Dis."},{"key":"10.1016\/j.jhep.2019.07.002_b0165","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1002\/hep.29303","article-title":"Significance of oliguria in critically ill patients with chronic liver disease","volume":"66","author":"Amathieu","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.07.002_b0170","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/j.cgh.2018.01.035","article-title":"Association between grade of acute on chronic liver failure and response to terlipressin and albumin in patients with hepatorenal syndrome","volume":"16","author":"Piano","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2019.07.002_b0175","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jhep.2010.11.020","article-title":"Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: relationship of serum creatinine to hemodynamics","volume":"55","author":"Boyer","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.07.002_b0180","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1111\/liv.12852","article-title":"New ICA criteria for the diagnosis of acute kidney injury in cirrhotic patients: can we use an imputed value of serum creatinine?","volume":"35","author":"Rosi","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2019.07.002_b0185","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1002\/lt.22128","article-title":"Inaccuracies of creatinine and creatinine-based equations in candidates for liver transplantation with low creatinine: impact on the model for end-stage liver disease score","volume":"16","author":"Francoz","year":"2010","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2019.07.002_b0190","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1002\/hep.26704","article-title":"Glomerular filtration rate equations for liver-kidney transplantation in patients with cirrhosis: validation of current recommendations","volume":"59","author":"Francoz","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.07.002_b0195","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.jhep.2016.05.025","article-title":"Kidney biomarkers in cirrhosis","volume":"65","author":"Francoz","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.07.002_b0200","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1053\/j.ajkd.2010.11.032","article-title":"Clinical applications of biomarkers for acute kidney injury","volume":"57","author":"Belcher","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jhep.2019.07.002_b0205","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/hep.26980","article-title":"Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury","volume":"60","author":"Belcher","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.07.002_b0210","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1007\/s10620-012-2180-x","article-title":"Urinary neutrophil gelatinase-associated lipocalin predicts mortality and identifies acute kidney injury in cirrhosis","volume":"57","author":"Verna","year":"2012","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2019.07.002_b0215","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jhep.2012.03.015","article-title":"Urinary neutrophil gelatinase- associated lipocalin as biomarker in the differential diagnosis of impairment of kidney function in cirrhosis","volume":"57","author":"Fagundes","year":"2012","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.jhep.2019.07.002_b0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128145","article-title":"Analysis of a urinary biomarker panel for clinical outcomes assessment in cirrhosis","volume":"10","author":"Ariza","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jhep.2019.07.002_b0225","doi-asserted-by":"crossref","DOI":"10.1002\/hep.30592","article-title":"Neutrophil gelatinase\u2010associated lipocalin for assessment of acute kidney injury in cirrhosis: a prospective study","author":"Huelin","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.07.002_b0230","doi-asserted-by":"crossref","first-page":"597","DOI":"10.7326\/0003-4819-96-5-597","article-title":"Nonoligouric acute renal failure associated with a low fractional excretion of sodium","volume":"96","author":"Diamond","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhep.2019.07.002_b0235","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/hep.29772","article-title":"Fractional excretion of urea: a simple tool for the differential diagnosis of acute kidney injury in cirrhosis","volume":"68","author":"Patidar","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.07.002_b0240","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/nrneph.2017.2","article-title":"Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup","volume":"13","author":"Chawla","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.jhep.2019.07.002_b0245","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1136\/gut.2010.236133","article-title":"Working Party proposal for a revised classification system of renal dysfunction in patients with cirrhosis","volume":"60","author":"Wong","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2019.07.002_b0250","doi-asserted-by":"crossref","unstructured":"EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018; 69: 406\u2013460.","DOI":"10.1016\/j.jhep.2018.03.024"},{"key":"10.1016\/j.jhep.2019.07.002_b0255","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jhep.2013.07.044","article-title":"Pathological bacterial translocation in liver cirrhosis","volume":"60","author":"Wiest","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.07.002_b0260","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/hep.510270507","article-title":"Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality","volume":"27","author":"Navasa","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.07.002_b0265","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1007\/s10620-015-3921-4","article-title":"SIRS at admission is a predictor of AKI development and mortality in hospitalized patients with severe alcoholic hepatitis","volume":"61","author":"Maiwall","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2019.07.002_b0270","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/liv.12047","article-title":"Increased renal expression and urinary excretion of TLR4 in acute kidney injury associated with cirrhosis","volume":"33","author":"Shah","year":"2013","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2019.07.002_b0275","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jhep.2011.11.024","article-title":"Prevention of acute kidney injury in a rodent model of cirrhosis following selective gut decontamination is associated with reduced renal TLR4 expression","volume":"56","author":"Shah","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.07.002_b0280","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/SHK.0000000000000052","article-title":"A unified theory of sepsis-induced acute kidney injury: inflammation, microcirculatory dysfunction, bioenergetics, and the tubular cell adaptation to injury","volume":"41","author":"Gomez","year":"2014","journal-title":"Shock"},{"key":"10.1016\/j.jhep.2019.07.002_b0285","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1002\/hep.26599","article-title":"Bile acids trigger cholemic nephropathy in common bile-duct-ligated mice","volume":"58","author":"Ficket","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.07.002_b0290","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/ki.2013.78","article-title":"Bile cast nephropathy is a common pathologic finding for kidney injury associated with severe liver dysfunction","volume":"84","author":"Van Slambrouck","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.jhep.2019.07.002_b0295","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/j.1478-3231.2009.02182.x","article-title":"The spectrum of renal lesions in patients with cirrhosis: a clinicopathological study","volume":"30","author":"Trawal\u00e9","year":"2010","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2019.07.002_b0300","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1111\/j.1600-6143.2008.02426.x","article-title":"Kidney allocation to liver transplant candidates with renal failure of undetermined etiology: role of percutaneous renal biopsy","volume":"8","author":"Wadei","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2019.07.002_b0305","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0168-8278(00)80158-0","article-title":"Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome","volume":"33","author":"Uriz","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.07.002_b0310","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1053\/gast.2002.32364","article-title":"Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a restrospective multicenter study","volume":"4","author":"Moreau","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2019.07.002_b0315","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1053\/jhep.2002.35819","article-title":"Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study","volume":"36","author":"Ortega","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.07.002_b0320","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1053\/j.gastro.2008.02.024","article-title":"Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study","volume":"134","author":"Martin-Llahi","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2019.07.002_b0325","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.jhep.2013.12.032","article-title":"Terlipressin and albumin for type-1 hepatorenal syndrome associated with sepsis","volume":"60","author":"Rodr\u00edguez","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.07.002_b0330","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/hep.27709","article-title":"Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: a randomized trial","volume":"62","author":"Cavallin","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.07.002_b0335","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1053\/j.gastro.2016.02.026","article-title":"Terlipressin plus albumin is more effective than albumin alone in improving renal function in patients with cirrhosis and hepatorenal syndrome type 1","volume":"150","author":"Boyer","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2019.07.002_b0340","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/hep.28396","article-title":"Terlipressin given by continuous intravenous infusion versus intravenous boluses in the treatment of hepatorenal syndrome: A randomized controlled study","volume":"63","author":"Cavallin","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.07.002_b0345","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/hep.510290629","article-title":"Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide","volume":"29","author":"Angeli","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.07.002_b0350","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.jhep.2012.01.012","article-title":"Noradrenaline vs. terlipressin in the treatment of hepatorenal syndrome: a randomized study","volume":"56","author":"Singh","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.07.002_b0355","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1111\/j.1572-0241.2008.01828.x","article-title":"An open label, pilot, randomized controlled trial of noradrenaline versus terlipressin in the treatment of type 1 hepatorenal syndrome and predictors of response","volume":"103","author":"Sharma","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2019.07.002_b0360","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1007\/s10620-006-9312-0","article-title":"Octreotide\/Midodrine therapy significantly improves renal function and 30-day survival in patients with type 1 hepatorenal syndrome","volume":"52","author":"Esrailian","year":"2007","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2019.07.002_b0365","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/hep.23286","article-title":"Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome","volume":"51","author":"Gluud","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.07.002_b0370","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S2468-1253(16)30157-1","article-title":"Comparative effi cacy of pharmacological strategies for management of type 1 hepatorenal syndrome: a systematic review and network meta-analysis","volume":"2","author":"Facciorusso","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.jhep.2019.07.002_b0375","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41572-018-0022-7","article-title":"Hepatorenal syndrome","volume":"4","author":"Gin\u00e8s","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jhep.2019.07.002_b0380","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/hep.20829","article-title":"A randomized unblinded pilot study comparing albumin versus hydroxyethyl starch in spontaneous bacterial peritonitis","volume":"42","author":"Fern\u00e1ndez","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.07.002_b0385","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/hep.26021","article-title":"Positive cardiac inotropic effect of albumin infusion in rodents with cirrhosis and ascites: molecular mechanisms","volume":"57","author":"Bortoluzzi","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.07.002_b0390","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2019.03.021","article-title":"Effects of albumin treatment on systemic and portal hemodynamics and systemic inflammation in patients with decompensated cirrhosis","author":"Fern\u00e1ndez","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2019.07.002_b0395","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0168-8278(97)80428-X","article-title":"Time profile of the haemodynamic effects of terlipressin in portal hypertension","volume":"26","author":"Escorsell","year":"1997","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.07.002_b0400","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jhep.2007.04.010","article-title":"Noradrenalin vs terlipressin in patients with hepatorenal syndrome: a prospective, randomized, unblinded, pilot study","volume":"47","author":"Alessandria","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.07.002_b0405","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/lt.24210","article-title":"Treatment of type 2 hepatorenal syndrome in patients awaiting transplantation: effects on kidney function and transplantation outcomes","volume":"21","author":"Rodriguez","year":"2015","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2019.07.002_b0410","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2147\/CEG.S153858","article-title":"Noradrenaline for reverting hepatorenal syndrome: a prospective, observational, single-center study","volume":"11","author":"Gupta","year":"2018","journal-title":"Clin Exp Gastroenterol"},{"key":"10.1016\/j.jhep.2019.07.002_b0415","article-title":"Terlipressin is superior to noradrenaline in the management of acute kidney injury in acute on chronic liver failure","author":"Arora","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.07.002_b0420","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1097\/TP.0b013e3181d7c40c","article-title":"Effects of phlebotomy and phenylephrine infusion on portal venous pressure and systemic hemodynamics during liver transplantation","volume":"89","author":"Massicotte","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2019.07.002_b0490","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1053\/jhep.2002.36501","article-title":"Terlipressin inhibits in vivo aortic iNOS expression induced by lipopolysaccharide in rats with biliary cirrhosis.","volume":"36","author":"Moreau","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.07.002_b0425","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1111\/j.1440-1746.2009.05873.x","article-title":"Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis","volume":"24","author":"Narahara","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2019.07.002_b0430","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0168-8278(03)00160-0","article-title":"Plasma volume expansion by albumin in cirrhosis. Relation to blood volume distribution, arterial compliance and severity of disease","volume":"39","author":"Brinch","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.07.002_b0435","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/hep.27322","article-title":"Posttranscriptional changes of serum albumin: clinical and prognostic significance in hospitalized patients with cirrhosis","volume":"60","author":"Domenicali","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.07.002_b0440","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1002\/lt.22395","article-title":"Impact of liver transplantation on the survival of patients treated for hepatorenal syndrome type 1","volume":"17","author":"Boyer","year":"2011","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2019.07.002_b0445","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/lt.24049","article-title":"Outcomes of patients with cirrhosis and hepatorenal syndrome type 1 treated with liver transplantation","volume":"21","author":"Wong","year":"2015","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2019.07.002_b0450","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/ajt.13631","article-title":"Simultaneous liver-kidney allocation policy: a proposal to optimize appropriate utilization of scarce resources","volume":"16","author":"Formica","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2019.07.002_b0455","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/lt.21149","article-title":"Hepatorenal syndrome: a proposal for kidney after liver transplantation (KALT)","volume":"13","author":"Ruiz","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2019.07.002_b0460","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1111\/j.1600-6143.2008.02416.x","article-title":"Proceedings of consensus conference on simultaneous liver kidney transplantation (SLK)","volume":"8","author":"Eason","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2019.07.002_b0465","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1111\/j.1600-6143.2007.01856.x","article-title":"Simultaneous liver-kidney transplantation: evaluation to decision making","volume":"7","author":"Davis","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2019.07.002_b0470","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1111\/j.1600-6143.2012.04190.x","article-title":"Simultaneous liver-kidney transplantation summit: current state and future directions","volume":"12","author":"Nadim","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2019.07.002_b0475","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/lt.23384","article-title":"Impact of the etiology of acute kidney injury on outcomes following liver transplantation: acute tubular necrosis versus hepatorenal syndrome","volume":"18","author":"Nadim","year":"2012","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2019.07.002_b0480","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/hep.20687","article-title":"MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation","volume":"41","author":"Alessandria","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.07.002_b0485","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.jhep.2012.06.024","article-title":"Hepatorenal syndrome, MELD score and liver transplantation: an evolving issue with relevant implications for clinical practice","volume":"57","author":"Angeli","year":"2012","journal-title":"J Hepatol"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827819304106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827819304106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:37:25Z","timestamp":1759174645000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827819304106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":98,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S0168827819304106"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2019.07.002","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.736200857.793585179","asserted-by":"object"}]},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"News in pathophysiology, definition and classification of hepatorenal syndrome: A step beyond the International Club of Ascites (ICA) consensus document","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2019.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V. on behalf of European Association for the Study of the Liver.","name":"copyright","label":"Copyright"}]}}